Cited 0 times in
Association of multiplex-immunofluorescence (m-IF) and gene expression signature with prognosis and bevacizumab (bev) treatment outcomes in NRG oncology/NSABP C-08: Implications for combining immune checkpoint blockade (ICB) and bev
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.